227 related articles for article (PubMed ID: 14595753)
1. Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells.
Emmerich F; Theurich S; Hummel M; Haeffker A; Vry MS; Döhner K; Bommert K; Stein H; Dörken B
J Pathol; 2003 Nov; 201(3):413-20. PubMed ID: 14595753
[TBL] [Abstract][Full Text] [Related]
2. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.
Horie R; Watanabe T; Morishita Y; Ito K; Ishida T; Kanegae Y; Saito I; Higashihara M; Mori S; Kadin ME; Watanabe T
Oncogene; 2002 Apr; 21(16):2493-503. PubMed ID: 11971184
[TBL] [Abstract][Full Text] [Related]
3. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
Izban KF; Ergin M; Martinez RL; Alkan S
Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
[TBL] [Abstract][Full Text] [Related]
4. Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma.
Schmidt A; Schmitz R; Giefing M; Martin-Subero JI; Gesk S; Vater I; Massow A; Maggio E; Schneider M; Hansmann ML; Siebert R; Küppers R
Genes Chromosomes Cancer; 2010 Sep; 49(9):803-9. PubMed ID: 20607853
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells.
Emmerich F; Meiser M; Hummel M; Demel G; Foss HD; Jundt F; Mathas S; Krappmann D; Scheidereit C; Stein H; Dörken B
Blood; 1999 Nov; 94(9):3129-34. PubMed ID: 10556199
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
[TBL] [Abstract][Full Text] [Related]
7. The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma.
Nakashima M; Ishii Y; Watanabe M; Togano T; Umezawa K; Higashihara M; Watanabe T; Horie R
Cancer Sci; 2010 Nov; 101(11):2490-6. PubMed ID: 20735433
[TBL] [Abstract][Full Text] [Related]
8. Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed-Sternberg cells.
Schwarzer R; Dörken B; Jundt F
Leukemia; 2012 Apr; 26(4):806-13. PubMed ID: 21946908
[TBL] [Abstract][Full Text] [Related]
9. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
[TBL] [Abstract][Full Text] [Related]
10. Dimeric procyanidin B2 inhibits constitutively active NF-kappaB in Hodgkin's lymphoma cells independently of the presence of IkappaB mutations.
Mackenzie GG; Adamo AM; Decker NP; Oteiza PI
Biochem Pharmacol; 2008 Apr; 75(7):1461-71. PubMed ID: 18275936
[TBL] [Abstract][Full Text] [Related]
11. The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.
Schneider EM; Torlakovic E; Stühler A; Diehl V; Tesch H; Giebel B
J Pathol; 2004 Dec; 204(5):538-45. PubMed ID: 15538755
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.
Krappmann D; Emmerich F; Kordes U; Scharschmidt E; Dörken B; Scheidereit C
Oncogene; 1999 Jan; 18(4):943-53. PubMed ID: 10023670
[TBL] [Abstract][Full Text] [Related]
13. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs.
Van Vlierberghe P; De Weer A; Mestdagh P; Feys T; De Preter K; De Paepe P; Lambein K; Vandesompele J; Van Roy N; Verhasselt B; Poppe B; Speleman F
Br J Haematol; 2009 Dec; 147(5):686-90. PubMed ID: 19775296
[TBL] [Abstract][Full Text] [Related]
14. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.
Bargou RC; Emmerich F; Krappmann D; Bommert K; Mapara MY; Arnold W; Royer HD; Grinstein E; Greiner A; Scheidereit C; Dörken B
J Clin Invest; 1997 Dec; 100(12):2961-9. PubMed ID: 9399941
[TBL] [Abstract][Full Text] [Related]
15. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma.
van den Berg A; Kroesen BJ; Kooistra K; de Jong D; Briggs J; Blokzijl T; Jacobs S; Kluiver J; Diepstra A; Maggio E; Poppema S
Genes Chromosomes Cancer; 2003 May; 37(1):20-8. PubMed ID: 12661002
[TBL] [Abstract][Full Text] [Related]
16. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
[TBL] [Abstract][Full Text] [Related]
17. The molecular pathogenesis of Hodgkin lymphoma.
Farrell K; Jarrett RF
Histopathology; 2011 Jan; 58(1):15-25. PubMed ID: 21261680
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis of Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma revisited.
Benharroch D; Einav I; Feldman A; Levy A; Ariad S; Gopas J
APMIS; 2010 May; 118(5):339-45. PubMed ID: 20477808
[TBL] [Abstract][Full Text] [Related]
19. [The molecular pathogenesis of classical Hodgkin lymphoma].
Mathas S; Dörken B; Janz M
Dtsch Med Wochenschr; 2009 Sep; 134(39):1944-8. PubMed ID: 19760557
[TBL] [Abstract][Full Text] [Related]
20. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
